Table 2 Exposure to the different biologic response modifiers depending on diagnosis in BIOBADASER
Diagnosis | Infliximab | Etanercept | Adalimumab |
|---|---|---|---|
Rheumatoid arthritis | 5,521 (840) | 1,724 (188) | 526 (67) |
All spondylarthritis | 1,915 (211) | 507 (35) | 5.7 (3) |
Ankylosing spondylitis | 873 (87) | 134 (13) | 0.8 (0) |
Psoriatic arthritis | 636 (84) | 325 (16) | 2.6 (2) |
Undifferentiated spondylarthritis | 257 (28) | 35 (4) | 1.4 (0) |
Crohn's related spondylarthritis | 124 (9) | 2.8 (0) | 0.7 (0) |
Other spondylarthritis | 22 (3) | 9.5 (2) | 0.3 (1) |